New Study Links Depo-Provera to Higher Risk of Brain Tumor October 6, 2025 A new study published in JAMA Neurology in September 2025 found that women in the United States who use the birth control shot Depo-Provera (depot medroxyprogesterone acetate, or DMPA) may face a higher risk of developing meningioma, a type of brain tumor that forms in the membranes surrounding the brain and spinal cord. Key Findings […] Read More
Do You Have a Depo-Provera Case? Understanding Your Rights After a Meningioma Diagnosis September 2, 2025 Depo-Provera Lawsuit News Read More
Pfizer’s ‘Depo-Provera’ Increases Risk of Brain Tumours 3.5 Times Compared to Combined Birth Control Pill According to New Study as Litigation Overseen by Levin Papantonio Rises to Over 550 Lawsuits July 28, 2025 A new study published on 29 June 2025 in international peer-reviewed medical journal Expert Opinion on Drug Safety by Frey et al. (the Frey study) has found that use of depot medroxyprogesterone acetate(DMPA), which is manufactured by Pfizer Inc. (NYSE:PFE) and sold under the brand name Depo-Provera among others, for over one year is associated […] Read More
Levin Law
Levin Law